Cytomegalovirus: Phase II data

Top-line data from a double-blind, international Phase II trial in 150 CMV-seronegative kidney transplant recipients receiving an organ from a CMV-seropositive donor

Read the full 226 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE